Owen N. Witte is of Allogene Therapeutics, Inc.. Currently has a direct ownership of 292,832 shares of ALLO, which is worth approximately $547,595. The most recent transaction as insider was on Jun 13, 2023, when has been sold 74,561 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 293K
0% 3M change
0% 12M change
Total Value Held $547,595

OWEN N. WITTE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
BUY
Grant, award, or other acquisition
-
74,561 Added 20.29%
292,832 Common Stock
Aug 12 2022
SELL
Open market or private sale
$86,250 $17.25 p/Share
5,000 Reduced 2.24%
218,271 Common Stock
Aug 12 2022
SELL
Open market or private sale
$86,250 $17.25 p/Share
5,000 Reduced 2.24%
218,271 Common Stock
Aug 11 2022
SELL
Open market or private sale
$165,000 $16.5 p/Share
10,000 Reduced 4.29%
223,271 Common Stock
Aug 11 2022
SELL
Open market or private sale
$165,000 $16.5 p/Share
10,000 Reduced 4.29%
223,271 Common Stock
Jun 22 2022
SELL
Open market or private sale
$117,600 $11.76 p/Share
10,000 Reduced 4.11%
233,271 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
22,089 Added 8.32%
243,271 Common Stock
Sep 09 2021
SELL
Open market or private sale
$127,700 $25.54 p/Share
5,000 Reduced 2.21%
221,182 Common Stock
Aug 20 2021
SELL
Open market or private sale
$234,700 $23.47 p/Share
10,000 Reduced 4.23%
226,182 Common Stock
Jun 09 2021
SELL
Open market or private sale
$249,723 $25.05 p/Share
9,969 Reduced 4.05%
236,182 Common Stock
ONW

Owen N. Witte

South San Francisco, CA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO